Just floated this morning on plus markets and looks very reasonably priced. 1.5 million raised at 35p per share. Market cap just over 6 million. Companys profitable and trades on a forward P/E to May 2008 of circa 10.7. Management team look sound and growth should be on the agenda. One to tuck away I feel. Well worth further consideration.

GENERAL MEDICAL CLINICS PLC PLUS-quoted
Profile
GENERAL MEDICAL CLINICS PLC

General Medical Clinics Plc ("GenMed") provides primary medical care in the
City specialising in general practice, health screening services, occupational
health programmes, physiotherapy, and nurse-led functions such as travel
vaccinations.

Operating three private clinics, in 2005 it won a five year contract from the
Department of Health ("DH") to operate the first privately run NHS Walk-in
Centre in London paying a stable monthly income stream plus payments per
patient seen.

GenMed's core product provides private GP services including the Company Doctor
Scheme with corporate organisations paying a fixed fee per employee covering
unlimited consultations with a doctor or nurse.

The Scheme's stable source of annual income is enhanced by self-pay membership
programmes and self-pay walk-in services.

GenMed intends to bid for new contracts for services to the DH within the M25
region.

Company website........
http://www.genmed.org.uk

Link to plus market...

http://www.plusmarketsgroup.com/details.shtml?ISIN=GB00B1LD2D14

Nb, no chart available yet.

DYOR.

A very bullish article from UQ analyst.com........

General Medical Clinics - Interim results

Plus Markets newbee, General Medical this morning unveiled a robust set of interim numbers for the six month period to 30th November. The group, which provides primary medical care in the City, specialising in general practice, health screening and occupational health, unveiled an 18.7% rise in revenues to 3.2 million, with operating profits up ten fold to 220,908. The interim numbers contained a one-off exceptional expense of 340,645 relating to the cancellation of the majority of outstanding share option agreements. Excluding this item, basic earnings per share for the period came in at 1.86p on a fully-diluted basis. Including the exceptional costs, of which just 56,816 related to cash items, the loss per share figure came in at 1.09p.

GenMed operates three private clinics and, under contract with the Department of Health, an NHS Walk-in centre. GenMeds Company Doctor Scheme provides unlimited consultations for a fixed fee per staff member, affording the company a stable source of annual income, further enhanced by self-pay membership programmes together with walk-in services. Demand for GenMed's services is growing and in the year ahead, the customer base should continue to move ahead nicely, especially with the launch of new services to complement the existing range of medical and health products, accompanied with continued exploratory talks with possible acquisition candidates.

The steady increase in turnover since the acquisition of Finsbury Healthcare in 2004 together with the opening of the Liverpool Street NHS Walk-In Centre in December 2005, continued during the period as the demand for convenient and accessible medical services grew. This is particularly evident in the City but is an apparent trend in all areas with a high office bound working population. And so, supported by a strong balance sheet, which boasts a 1.3 million net cash position, GenMed is more than likely to expand its outlets in the coming months.

Excluding exceptional items, we see no reason why earnings won't hit close to 4p in the current year. A group that is well managed and operating in a high growth sector deserves to trade at a premium, and thus, the prospective pre-exceptional earnings multiple of 12 far from discounts the phenomenal growth potential. Furthermore, this is a company supported by a solid balance sheet, with more than sufficient financial resources to drive earnings forward via a carefully executed acquisition strategy. At 48p, General Medical Clinics is valued at 7.97 million and represents a resounding buy.

Director buys..

General Medical Clinics plc - Director's Shareholding


GENERAL MEDICAL CLINICS PLC
("GENMED" OR THE "COMPANY")

DIRECTOR'S HOLDING IN THE COMPANY

General Medical Clinics plc (PLUS: GMCP), an established provider of primary
medical care in the City of London, today announces that the following share
transactions have been notified to the Company:

1. Acquisition by Mr Nicholas Davis, a director of the Company:

Number of shares prior to the transaction: 0
Date of the transaction: 15-February-2007
Date on which issuer notified: 15-February-2007
Type of Shares: Ordinary Shares of 5p
Number of Shares: 25,000
Total holding following transaction: 25,000
Price paid per share: 45p

2. Acquisition by Lend Lease Property Corporation Limited. Mr Nicholas Davis is
a director of Lend Lease Property Corporation Limited:

Number of shares prior to the transaction: 1,872,457
Date of the transaction: 15-February-2007
Date on which issuer notified: 15-February-2007
Type of Shares: Ordinary Shares of 5p
Number of Shares: 27,543
Total holding following transaction: 1,900,000
Price paid per share: 45p

Lend Lease Property Corporation Limited's total shareholding now represents
11.44% of the issued share capital the Company.

The total issued share capital of GenMed is 16,606,190 ordinary shares of 5p
each and following the above transactions the interests of the directors now
total 3,538,903 shares representing 21.31% of the issued share capital of the
Company.


ENQUIRIES:

------------------------------------------------
|GENERAL MEDICAL CLINICS PLC | |
------------------------------------------------
|Harry Hyman, Chairman |07973 344 768|

A big contract win this morning, trades far too low on a forward P/E of circa 11...

General Medical Clinics plc - Contract for travel health clinics


GENERAL MEDICAL CLINICS PLC

EXCLUSIVE CONTRACT FOR TRAVEL HEALTH CLINICS IN THE CITY OF LONDON


General Medical Clinics PLC (PLUS: GMCP) ("GenMed") an established provider of
primary care in the City of London which was admitted to trading on PLUS on 29
December 2006, announces an exclusive agreement with MASTA Ltd ("MASTA"), a
leading travel vaccination and travel health advice company in the UK. MASTA
has acquired the status of British Airways Preferred Partner for travel health
services and runs the largest and most successful network of private travel
clinics in the UK.

The agreement grants GenMed exclusivity for the City of London by way of a
Partnership agreement. The nurse-led MASTA travel clinic will initially be
operating out of the Fleet Street Medical Centre with a plan to open two more
in the City. The staff will receive additional specialist training with regards
to vaccinations, immunisations and detailed travel health advice. There are
already 30 Partner clinics in the UK, with this number expected to reach 40 by
2010.

This exclusive agreement with a well known brand name will provide GenMed with
an additional revenue stream and greater recognition. The benefits include
more exposure, especially with institutional clients, additional business in
new areas, return clientele, and numerous marketing opportunities. MASTA's
established in-house marketing structure will provide substantial exposure for
GenMed at minimal cost.


JERRY APPLEYARD, CHIEF EXECUTIVE, COMMENTED:

"THIS IS A GREAT STEP FORWARD FOR GENMED AND IS INDICATIVE OF OUR ACTIVE
APPROACH TO NEW BUSINESS DEVELOPMENT. BY ESTABLISHING MASTA TRAVEL HEALTH
CLINICS AT OUR EXISTING LOCATIONS, WE WILL ENJOY ADDITIONAL REVENUE,
RECOGNITION AND BRAND NAME MARKETING.

"WE LOOK FORWARD TO SERVING THE CITY OF LONDON COMMUNITY FOR ITS TRAVEL
VACCINATION NEEDS AND DEVELOPING FURTHER OUR RANGE OF CARE PROVISION."

26 FEBRUARY 2007

The directors of General Medical Clinics PLC accept responsibility for this
announcement.


ENQUIRIES:

------------------------------------------------
|GENERAL MEDICAL CLINICS PLC |020 7427 0605|

__________________

From UQ analyst

General Medical strikes health clinic deal

Pay-per-visit doctor surgery business General Medical Clinics has struck a cracking deal with travel health business MASTA. Having just acquired the status of "British Airways Preferred Partner" for travel health services, MASTA's tie up with General Medical Clinics' should further cement the latters' position as the leading clinic service in the City.

Today's agreement grants GenMed exclusivity for the City of London by way of a Partnership agreement. The nurse-led MASTA travel clinic will initially be operating out of the Fleet Street Medical Centre with a plan to open two more centres in the City. The staff will receive additional specialist training with regards to vaccinations, immunisations and detailed travel health advice. There are already 30 Partner clinics in the UK, with this number expected to reach 40 by 2010.

This exclusive agreement with a well known brand name will provide GenMed with an additional revenue stream and greater recognition. Clearly if a patient visits to have a vaccination administered, they may come back for other services too. Furthermore, MASTA's established in-house marketing structure will provide substantial exposure for GenMed at minimal cost.

And so to the numbers. Excluding exceptional items, we see no reason why earnings won't hit close to 4p in the current year. A group that is well managed and operating in a high growth sector deserves to trade at a premium, and thus, the prospective pre-exceptional earnings multiple of 11 far from discounts the phenomenal growth potential. Furthermore, this is a company supported by a solid balance sheet, with more than sufficient financial resources to drive earnings forward via a carefully executed acquisition strategy. At 44p, General Medical Clinics is valued at 7.5 million and is a resounding buy.

Buy Plus listed General Medical Clinics at 44.5p

A tip from Rebecca Turner, editor of the AIM and Plus Newsletter

General Medical Clinics is the latest in a line of promising companies to float on the recently revived PLUS market. The group, which is affectionately known as
GenMed by bulletin board luvvies, sneaked onto the market on the final business day of 2006, following a fundraising of 4.2 million shares at 35p raising 1.5 million. Having received a warm welcome from the investment community, who quickly snapped up shares following its listing; this profitable and fast growing company is now focused on beefing up its bottom line by capitalizing on the growing demand of private health
services.

Founded in 1998, GenMed now operates three private clinics, Broadgate Medical Centre, Walk in Health and Finsbury Medical Centre where it offers general practice,
health screening services, occupational health programs and physiotherapy. Its product services are provided in a number of forms, including private GP services and a Company Doctor Scheme where companies can pay a fixed fee to cover unlimited consultations for their employees. Its service is one based on convenience.
But its service is one that arguably adds real value to its corporate clients. For staff working in the City, GenMed offers in-house services for its clients, allowing employees to make the most of the services offered by the group without being absent from work.
On a financial level, these corporate contracts are a dream ticket.

Not only do they provide the company with an attractive income stream, but moreover, as payments are made a year in advance, the group can enjoy a certain degree of earnings visibility. Having recognized the importance of a reliable earnings stream, GenMed is now in the process of negotiating the extension of these payments for up to three years, thus creating visibility of earnings and sustainable revenues. Elsewhere in the portfolio, the privately run NHS centre has been profitable from its inception. This is mostly due to an agreement with the Department of Health to pay a stable monthly income stream to GenMed plus a payment per patient seen. Together with the Company Doctor Scheme, the Department of Health contract generates 40% of the companys total revenues.

In the year to 31st May 2006, the company delivered a 150% rise in pre-tax profits to 365,059. Revenues rose by 36% to 5.6 million. As at 31st May 2006, the company
had cash at bank and in hand of 260,926 and working capital of 95,061. Since then of course, the balance sheet has been boosted by a 1.5 million cash injection. Indeed, GenMeds stronger balance sheet was heralded by the companys move into profitability in 2005.

The plan going forward is to ramp up the profitability of the business by opening further centres in and across London. GenMed has already appointed a Director of New Business whose main job will be to strengthen the sales arm of the business by approaching new companies, strengthening relationships with its existing clients
and maximize the cross-selling opportunities between the different services it provides to its existing customers. The management has implemented cost management
procedures and performance indicators measurements to monitor the progress of the business, with IT systems also now in place that have integrated the three private centres with online internet booking systems.

For the last financial year, the group delivered earnings of 2.7p per share. This figure should comfortably be up to 4p in the current year, with the potential to grow earnings significantly over the coming years as further contracts are won and acquisitions completed. This is a business that has quite phenomenal growth prospects, limited only by the managements ability to convert opportunity into profit. The current 7.39 million valuation far from discounts GenMeds growth prospects. Despite its relatively short history of profitability, GenMed is in a fine position to deliver further growth and warrant a far greater valuation.

Key Data

EPIC: GMCP
Market: PLUS
Spread: 43 - 46p

GF, delighted to say I have finally been able to have a look at this. Will definitely give it some thought. Many thanks also for you mail of several weeks ago, which I have also finally found time to look at.

No probs ST.

Glad to see you active and about.

Hope the general sell off hasnt caught you.

Thanks, GF. :o) I have made it back to England in one piece (although most of my stuff is buried in a pile of moving crates that will take me weeks to sort out!)

"Hope the general sell off hasnt caught you". Thanks; not enough to be damaging. Sold my SOLA last week, so that is the biggie out of the way. GNG took a bit of a hit today, but it has doubled in the past few weeks, so hardly surprising.

am trying to decide whether it's best just to keep my cash out of the market altogether for the time being or whether, for example, to have a pop at Entelos ahead of the results and then plan to invest the profits in GMCP for the longer term.

GF, didn't you mention one or two other Plus-quoted stocks a few weeks back that you thought were worth a look?

ST yep Master Mailer and Chemistry communications.

Re GMCP Broker Hardman have an inmminent update note. Ill let you have a copy once I receive it.

Glad to see you back in good old blighty.

Thanks GF - would be great to see that note on GMCP. I shall look into the other stocks too.

Nice to be back, too!

General Medical Clinics plc select Overview Profile Contacts Reports & Accounts Offerings News Market Data Charts

News
General Medical Clinics plc - Directorate shareholding distribution


GENERAL MEDICAL CLINICS PLC

DIRECTORATE SHAREHOLDING

CHIEF EXECUTIVE DISTRIBUTES SHAREHOLDING TO STAFF


General Medical Clinics PLC (PLUS: GMCP) ("GenMed") an established provider of
primary care in the City of London which was admitted to trading on PLUS on 29
December 2006, announces that Jerry Appleyard, Chief Executive has transferred
7000 ordinary shares, being his entire holding for nil consideration. The
shares have been gifted to staff across GenMed on an equal basis to provide
them with a personal interest in the business.

Following the above transactions the interests of the directors now total
3,531,903 shares representing 21.27% of the issued share capital of the
Company.


JERRY APPLEYARD, CHIEF EXECUTIVE, COMMENTED:

"I believe that all staff should hold shares in the company and not just the
directors. By allowing staff to hold shares there is a personal incentive to
focus on the future of the company."

16 March 2007

ENQUIRIES:

------------------------------------------------
|GENERAL MEDICAL CLINICS PLC |020 7427 0605|

Hey, good news...looks like Patricia Hewitt can't cope with the current NHS. What a wonderful idea. I will be able to buy my milk,, vegetables and have a quick prostatectomy at Tescos, and gain extra points. It;s so good to know Patricia that the NHS is safe in your hands.



From The Sunday Times - March 18, 2007

Retail giants set to run GP clinics by David Cracknell and Sarah-Kate Templeton

TONY BLAIR is to invite retail chains including Tesco, Virgin and Boots to bid to run GP surgeries on behalf of the NHS with contracts worth 225m over five years. GPs will be encouraged to run clinics at breakfast time and in the early evening in poor areas where conventional family doctors have been reluctant to practise.

Blairs announcement, to be made tomorrow, is intended to ensure Gordon Brown carries on his reforms of the NHS after Blair leaves Downing Street.

The prime minister will respond to Tory claims that he has left the NHS in crisis by publishing his ideas for progressive reform of public services. He will allow GPs to link up with pharmacies and supermarket drug counters by sharing electronic patient records.

In an indication that he is signed up to the scheme, the chancellor will announce measures to expand the use of community pharmacies for routine treatments and tests.

Tomorrow Blair will publish the first of six policy review papers, on public services, in an effort to shift the emphasis away from producers to consumers.

Patricia Hewitt, the health secretary, will name the first towns to take part in the new programme. Extra family practices, walk-in centres and minor injuries units will be opened in Har-tlepool, Durham, Mansfield and Great Yarmouth. Other areas will join the programme in the coming months.

Contracts for the new services will run for an initial five years, with the possibility of extension.

Although there is no national shortage of GPs, there are many underdoctored areas in England and Wales. The four areas involved in the first wave have significantly fewer GPs per person than the national average of 57.9 GPs per 100,000 people.

The programme aims to attract a broad range of providers, from existing entrepreneurial GPs to social enterprises and FTSE-100 companies. Some extra GPs and nurses will be recruited for up to 30 health blackspots to tackle local shortages of doctors.

David Cameron will also focus on the NHS in a speech to the Conservative partys spring forum in Nottingham today. He is expected to say: It used to be said that Labour were the party of the NHS. Not any more. Labour are the party that is undermining the health service.

Theres a simple reason why. Its not because they dont care. But it is because of their values and philosophy: Labours mania for controlling and directing things from the centre; Labours pessimism about human nature; Labours belief that if people arent told what to do, theyll do the wrong thing. Labour just dont trust people. nThousands of doctors staged marches in London and Glas-gow yesterday to protest at reforms to the system of medical training.

They accuse the government of trying to disempower and degrade the profession.

Could certainly be an opportunity here for GMCP.